Pdc - phosducin Gene

Also Known as Rpr1; Rpr-1

Species: Mus musculus

Gene Type: protein coding
Gene ID: 20028

Summary

Predicted to be involved in regulation of G protein-coupled receptor signaling pathway. Predicted to act upstream of or within visual perception. Located in photoreceptor outer segment. Is expressed in central nervous system; foot; skeleton; and spinal nerve plexus. Orthologous to human PDC (phosducin). [provided by Alliance of Genome Resources, Apr 2022]

Pdc Products (2)

mRNA Protein Name
NM_001159730.1 NP_001153202.1 phosducin
NM_024458.2 NP_077778.1 phosducin

Gene Ontology

  • Cellular Component
Cellular Component GO Annotation Evidence References Source
located in photoreceptor outer segment IDA
IDA: Inferred from direct assay
18367617 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

phosducin

  • 33 kDa phototransducing protein

  • PHD

  • rod photoreceptor 1

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99168 Anifrolumab Antagonist 99.79% Unkown

Clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-Y0445A Sodium dichloroacetate 99.78% Phase 3
HY-148511A Vidutolimod sodium Inhibitor 90.30% Phase 3
HY-139567 Afimetoran 99.37% Phase 2
HY-P2796 Pyruvate decarboxylase / Phase 2
HY-106195 L 377202 Ligand / Phase 2
HY-P4160 PDC31 Inhibitor 98.67% Phase 1
HY-P10762 Ricorfotide vedotin Ligand 98.45% Phase 1
HY-P10740 CBP-1018 Ligand 99.21% Phase 1
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Phase
HY-P99300 Ligelizumab Inhibitor 99.85% Phase 3
HY-P99226 Daxdilimab Inhibitor 97.82% Phase 2

Pre-clinical Phase

Bioactive Molecules (25)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-12836A IFN alpha-IFNAR-IN-1 hydrochloride Inhibitor 99.76% Unkown
HY-132296 GSK215 Inhibitor 99.26% Unkown
HY-P11072 IRF5-CPP5 Inhibitor 99.23% Unkown
HY-150217 CpG ODN 10101 Agonist 99.44% Unkown
HY-160719 2-octynoic acid-BSA / Unkown
HY-160231 ssRNA42 sodium Activator 98.62% Unkown
HY-P10741 DOTA-EB-TATE Activator 95.42% Unkown
HY-138794B XL177B 99.36% Unkown
HY-12836 IFN alpha-IFNAR-IN-1 Inhibitor 98.43% Unkown
HY-128606 Thiamine diphosphate analog 1 Activator / Unkown
HY-178489 BGC1614 / Unkown
HY-179166 PROTAC sEH degrader-4 Degrader / Unkown
HY-183717 M4K3233 / Unkown
HY-183718 M4K3250 Degrader / Unkown
HY-184389 PROTAC HDAC6 degrader 10 Degrader / Unkown
HY-188016 MC-GGFG-TriPtolide / Unkown
HY-P1094 AZ-10417808 Inhibitor / Unkown
HY-P11018 (123B9)2-L2-PTX Agonist / Unkown
HY-RS10184 PDC Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10777 PNKD Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-170838 PDHK1-IN-1 Inhibitor / Unkown
HY-182173 pdC-CE phosphoramidite / Unkown
HY-RS17399 Pdc Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23854 Pdc Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W800833 Benzyl N-[2-(prop-2-enamido)ethyl]carbamate / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990276 Anti-Mouse CD317/BST2 Antibody (927) Inhibitor ≥95.0% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Pdc NCBI NCBI:5132